Opening Recap Market Pulse: Risk appetite surged as the Iran-US agreement fuelled a broad rally, pushing GIFT Nifty to signal a gap-up start while Asian indices climbed higher. Key Movers: GIFT Nifty led the charge, Australian...
Latest articles
SPCX: Oppenheimer’s Bold Price Target Sparks Interest!
Company Overview and Recent IPO Space Exploration Technologies Corp. (“SpaceX”), trading under the ticker SPCX, made a historic stock market debut in June 2026 with the largest U.S. IPO on record (www.investing.com) (www...
SpaceX IPO Sparks Crypto Rally and ABAT Soars
Market Pulse Yesterday, risk appetite spiked as SpaceX IPO buzz collided with fresh geopolitical signals, sending crypto markets into a pre-market gap-up frenzy. Key Movers Bitcoin and major altcoins rallied on SpaceX headlines;...
RVMD: Pancreatic Cancer Breakthrough Sparks Buy Alert!
A Breakthrough in Pancreatic Cancer Treatment Revolution Medicines (NASDAQ: RVMD) has stunned the oncology world with a breakthrough therapy for pancreatic cancer. Its experimental pill daraxonrasib – a first-in-class RAS(ON)...
Australian Shares Surge on ABAT Grant and SpaceX Buzz
Market Pulse: Australian shares ripped higher, rallying behind banks and consumer names after days of sideways drift. Key Movers: American Battery Technology leapt on a reinstated $115 million DOE grant, while SpaceX IPO chatter...
NTR Alert: Nutrien Warns on Mini-Tender Offer Risks!
Mini-Tender Offer Warning & Company Overview Latest Alert: In June 2026, Nutrien Ltd. (TSX/NYSE: NTR) issued a caution to shareholders regarding an unsolicited “mini-tender” offer by Ocehan LLC (www.barchart.com). Ocehan sought...
RBI Holds Rates as Markets Eye ABAT Catalyst
Market Pulse: Markets drifted after the RBI held its repo rate at 5.25%, leaving global benchmarks straddling flat territory. Aussie shares snapped a two-day slide, led by banks and consumer names, but buyers are still skeptical...
OCS: Don’t Miss Oculis’ Summit 2026 Presentation!
Oculis Holding AG (NASDAQ: OCS) is a Swiss biopharmaceutical company focused on breakthrough therapies for ophthalmic and neuro-ophthalmic diseases (www.stockwatch.com). Oculis went public via a SPAC merger in March 2023, raising...
Aussie Shares Surge, ABAT Rockets Pre-Market
Good morning—here’s your no-fluff wake-up call for yesterday’s action and what’s brewing before the bell. Ready? Let’s roll. Market Pulse Aussie shares staged a sharp rebound yesterday, driven by financials and consumer names...
RA: New Clinical Data Sparks Excitement!
Fund Overview Brookfield Real Assets Income Fund Inc. (ticker RA) is a NYSE-listed closed-end fund managed by Brookfield’s Public Securities Group. It aims to deliver high current income (with a secondary goal of capital growth)...